Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Tilray

Why Does This Undervalued Cannabis Stock Have An Encouraging Outlook?

The Analyst

Benzinga

Analysts Going Hard On Tilray, Slashing Price Targets; How Much Adj. EBITDA Really Improved?

Tilray Brands, Inc.

Benzinga

EXCLUSIVE: Tilray CEO Shares Insider Insights Into Earnings, International Opportunities, Alcohol Market & More

Tilray Brands Inc.'s (NASDAQ: TLRY) CEO Irwin Simon said on Thursday's "Cannabis Insider" that "Europe will legalize [cannabis] before the U.S."

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Tilray's Fiscal 2022 Revenue Grows 22% YoY, Here Are The Details

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY) net revenue grew 8% to $153.3 million during the fourth quarter 2022, from $142.2 million in the prior year quarter.

Benzinga

What's Going On With Tilray Stock As Cannabis Legalization Bill Reaches Senate?

Tilray Brands, Inc (NASDAQ: TLRY) gapped up about 4.5% higher on Thursday on news that the Cannabis Administration And Opportunity Act (CAOA) has been introduced in the U.S. Senate.

Benzinga

Tilray Goes Through With It: Closes $155M Investment In HEXO, Expects $80M In Shared Savings

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY) has closed its acquisition from HT Investments MA LLC (“HTI”) of the secured convertible note issued by HEXO Corp. (NASDAQ: HEXO

Benzinga

Tilray's Good Supply Brand Expands Its Cannabis Portfolio In Québec

Tilray Brands, Inc.’s (NASDAQ: TLRY) (TSX:TLRY) cannabis brand Good Supply has expanded its product offering in Québec with the launch of Hash-Infused Pre-Rolls, in collaboration with the Société Québ&e

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Tilray Will Cover Employees' Travel, Accommodation & Paid Time Off For Women Seeking Reproductive Care

Tilray Brands Inc. (NASDAQ: TLRY) is joining other companies that are committing to help their employees travel to other states, following SCOTUS' decision to overturn Roe v.

Benzinga

Tilray Medical Expands Portfolio Of Medical Cannabis Products In The UK

Tilray Brands, Inc.’s (NASDAQ: TLRY) (TSX:TLRY) medical cannabis division, Tilray Medical, has expanded its medical cannabis offerings in the United Kingdom.

Benzinga

5 Value Stocks To Watch In The Healthcare Sector

What Defines a Value Stock?

Benzinga

Sentiment For Tilray Stock Should Improve, This Analyst Tells Us Why

Germany is inching toward legalizing recreational cannabis as the government seeks to have the process completed by the end of 2022. The latest push is coming from the country’s Health Ministry which undertook exper

Benzinga

Read Why Cantor Upgraded Aurora Cannabis Stock

Cantor Fitzgerald has upgraded Aurora Cannabis Inc (NASDAQ: ACB) to Overweight from Neutral

Benzinga

Tilray's Medical Cannabis Facility Visited By Government Of Luxembourg Delegation

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY) welcomed the Luxembourg Ministry of Health delegation to the company’s European campus and facility located in Cantanhede, Portugal.

Benzinga

HEXO Deal Could Be A Big Win For Tilray, This Analyst Tells Us Why

On Wednesday HEXO Corp (NASDAQ: HEXO) reported a staggering loss of CA$152.7 million ($118 million) in the third quarter of 2022, representing a

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

HEXO, Tilray Brands Amend Transaction Agreement, Here Are The Details

HEXO Corp. (TSX:HEXO) (NASDAQ: HEXO) has entered into an amending agreement to the transaction agreement with Tilray Brands, Inc. (NASDAQ:

Benzinga

Here's Why More Pain Looks Likely For Tilray Bulls

Tilray Inc (NASDAQ: TLRY) slipped to a new 52-week low on Thursday as the stock continued in a consistent 16-month downtrend that began in February 2021.

Benzinga

Tilray's Medical Cannabis Brand Aphria Launches Sleep-Oriented CBN Night Oil For Patients In Canada

Tilray Brands, Inc.'s (NASDAQ: TLRY) (TSX:TLRY) medical cannabis brand, Aphria, has launched CBN Night Oil, the brand’s first CBN oil medical product formulated for patients’ nighttime use.

Benzinga

Cannabis On Amazon? Why Tilray Stock Is Trading Higher

Tilray Brands Inc (NASDAQ: TLRY) shares are trading higher Thursday after the company announced the launch of its CBD lifestyle brand POLLEN on the Amazon.com Inc (NASDAQ: AMZN) UK platform.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Jim Cramer Explains What Needs To Happen For Cannabis Stocks To Bounce Back

Cannabis investors are in the midst of earnings season, which is also a timely opportunity to take a glimpse at the stock performance of some big players within the space.

Benzinga

Tilray's Good Supply Brand Expands High-Potency Cannabis Portfolio, Here Are The Details

Tilray Brands, Inc. (Nasdaq: TLRY) (TSX:TLRY) is expanding Good Supply's cannabis portfolio with the launch of new high-potency products including liquid wax vapes and exclusive new

Benzinga

Despite Recent Headwinds, U.S. Cannabis Industry "Doing Just Fine", According To Brady Cobb

In this week’s Trade To Black Podcast, TDR Founder Shadd Dales and contributor Anthony Varrell interviewed leading U.S. cannabis entrepreneur, advocate, and current CEO of Sunburn Cannabis, Brady Cobb. On the agenda were core agenda items of interest to cannabis investors, including the seemingly improving odds of SAFE Banking passage, how…

Benzinga

What's Going On With Tilray Shares Falling Near 52-Week Lows Today?

Shares of several companies in the broader cannabis and consumer discretionary sector, including Tilray Inc (NASDAQ: TLRY), are trading lower amid overall weakness as traders continue to digest Wednesday's Fed rate hike announcement.

Benzinga

10 Most-Searched Tickers On Benzinga Pro In April: Musk Mania, Apple Drops, Several Newcomers Move Up

Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers. Here is a look at the most-searched-for stocks on Benzinga Pro in the month of April.

Benzinga

This Analyst Has Mixed Feelings About Tilray's Promise To Achieve $4B In Revenue By 2024, Here's Why

Tilray Brands' (NASDAQ: TLRY) stock has plunged nearly 30% year-to-date.

Benzinga

Hexo Makes Leadership Changes, Appoints New CEO & CFO

HEXO Corp (NASDAQ: HEXO) (TSX:HEXO) announced that Charlie Bowman has been appointed the company’s acting president and CEO.

1 2 3 4

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.